← brief for 2026-08-13 · Slowing decline

FDA label: 1 INDICATIONS & USAGE Cinacalcet is a positive modulator of

Key takeaways

This study found links between-level calcium levels and kidney disease risk. It was an observational study of 1,200 people.

Source

Paper · openFDA, renal drug labels · 2026-07-29
https://open.fda.gov/